Glucocerebrosidase mutations and Parkinson disease

The discovery of glucocerebrosidase (GBA1) mutations as the greatest numerical genetic risk factor for the development of Parkinson disease (PD) resulted in a paradigm shift within the research landscape. Efforts to elucidate the mechanisms behind GBA1-associated PD have highlighted shared pathways...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Sophia R. L., Schapira, Anthony H. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463283/
https://www.ncbi.nlm.nih.gov/pubmed/35932311
http://dx.doi.org/10.1007/s00702-022-02531-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463283/
https://www.ncbi.nlm.nih.gov/pubmed/35932311
http://dx.doi.org/10.1007/s00702-022-02531-3

Ejemplares similares